The roles of exosomal immune checkpoint proteins in tumors
Abstract Targeting immune checkpoints has achieved great therapeutic effects in the treatment of early-stage tumors. However, most patients develop adaptive resistance to this therapy. The latest evidence demonstrates that tumor-derived exosomes may play a key role in systemic immune suppression and...
Enregistré dans:
Auteurs principaux: | Cheng Xing, Heng Li, Rui-Juan Li, Le Yin, Hui-Fang Zhang, Zi-Neng Huang, Zhao Cheng, Ji Li, Zhi-Hua Wang, Hong-Ling Peng |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cb7393321c9049f5bd1dda0f28ceda4e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2
par: Zhu J, et autres
Publié: (2021) -
Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review
par: Hong-Bo Li, et autres
Publié: (2021) -
Tumor-Associated Exosomes: A Potential Therapeutic Target for Restoring Anti-Tumor T Cell Responses in Human Tumor Microenvironments
par: Gautam N. Shenoy, et autres
Publié: (2021) -
Characterization of exosomes derived from Toxoplasma gondii and their functions in modulating immune responses
par: Li Y, et autres
Publié: (2018) -
Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors
par: Xue-lin Zou, et autres
Publié: (2021)